Hints and tips:
...associate professor at Harvard Medical School and Massachusetts General Hospital....
...The world faces a looming “retirement crisis” that requires a rethink of pensions and working patterns as medical breakthroughs boost longevity, BlackRock’s chief executive Larry Fink warned on Tuesday in...
...Uber’s return on capital last year was 3.1 per cent, according to S&P Capital IQ (ROC is basically after-tax profit divided by shareholders’ equity plus debt)....
...That compares against M3’s offer of ¥1,600 per share for up to a 55 per cent stake in Benefit One....
...Walmart aims to build more than 75 medical centres in the US by the end of 2024. Dollar General is testing mobile health clinics outside some of its stores....
...The Renaissance Capital IPO Index, which tracks issues for two years after listing, is down 54 per cent over the past 12 months, far worse that the S&P 500 index....
...A number of Chinese tech names have listed in Zurich, including lithium battery producers Gotion High-Tech and Sunwoda Electronic, medical device maker Lepu Medical Technology Beijing, and hand tool manufacturer...
...“K-S-I! K-S-I! K-S-I!” they chanted. At 10.30pm, after several other YouTubers-cum-boxers had taken their turns in the ring, KSI appeared. He wore a pink outfit and sang the national anthem....
...(Ethan Wu) One good read The case that we’re witnessing “an unprecedented watershed of medical innovation”....
...Reese Witherspoon sold her company Hello Sunshine to Blackstone for $900mn in 2021, for example, and Blackstone-backed Candle Media took a $60mn stake in Will Smith and Jada Pinkett Smith’s Westbrook Inc...
...and Invesco, before jumping ship to benchmarking giant S&P....
...Plus, the FT’s chief leader writer, Neil Buckley shares some of the FT’s predictions when it comes to 2022’s top stories....
...Live Nation Entertainment, which puts on live concerts that have been curtailed by social restrictions through the pandemic, led the S&P 500 higher in morning trading in New York, up 14 per cent....
...at S&P....
...Unlike vaccines, which target Covid-19’s spike protein, molnupiravir acts on the virus’s RNA genetic material....
...That has not arrested the decline in shares which have fallen 46 per cent in the past five years and trade at 11 times forward earnings, according to S&P Global....
...Wall Street’s blue-chip S&P 500 index gained 0.8 per cent in New York, climbing for a second day to reverse the entirety of Monday’s sharp drop....
...The strategy could be particularly important for the adenovirus vector vaccines from AstraZeneca and J&J, where the genetic code of Sars-Cov-2’s spike protein is carried in an inactivated cold virus....
...Several are more traditional shots, like the jab under development at GSK and Sanofi, that were leapfrogged by 2020’s breakthrough mRNA jabs....
FT tracker shows rapid growth in doses administered around world — but warnings come of long road ahead
...The company inserts the genes for Sars-Cov-2’s spike protein into an insect virus. The virus infects moth cells, which scale up the proteins....
...News that the coronavirus vaccine developed by Pfizer and BioNTech is more than 90 per cent effective sent investors into a buying spree and the S&P 500 to a new high....
...It previously blocked known individuals ahead of events — a policy that began with 2017’s deadly “Unite the Right” rally in Charlottesville, Virginia....
...That is well above the broader S&P 500 healthcare sector’s 16 times. That premium is not solid....
...Pfizer’s shares rose 2.7 per cent on Tuesday afternoon to $42.37, while the S&P 500 share index rose 0.3 per cent....
International Edition